After nearly two years of concerted effort with its dedicated partners, BioOne launched its new platform (www.bioone.org) on Tuesday, January 27, featuring a new look and improved content tools and features. BioOne’s upgraded platform is serviced by Allen Press and powered by Atypon Systems. BioOne embarked on this project to bring new functionality and a more user-friendly interface to all of its community members: researchers, participating publishers, and subscribing libraries.
Among its many new features designed with our users in mind, BioOne now includes personalized profiles through “My BioOne” allowing for saved searches, favorite journals, and e-alerting preferences, article and title-level tools such as RSS feeds, related article and author searches, and toll-free linking.
The site now offers BioOne participating publishers previously unavailable branding, customization, and promotional opportunities, including dedicated informational pages for each publication and society.
For BioOne subscribing libraries, BioOne is pleased to offer an increase in core access and reporting functionality including easy download of COUNTER statistics and MARC records, Open URL compliance and Shibboleth supported access.
We invite you to log-on to BioOne (www.bioone.org) and see these and other improvements for yourself. We welcome and rely on your feedback to continue to improve the site and better serve our communities. Users at subscribing institutions will be IP-authenticated as in the past. To log-in to “My BioOne” and access your profile, please enter your email address and the password used on the previous BioOne site (for a reminder, please contact firstname.lastname@example.org).
On behalf of everyone at BioOne, thank you to all those individuals and partner organizations that made this migration possible, including, but not limited to Allen Press, Atypon Systems, Portico, and Innodata-Isogen. The launch of the new BioOne platform marks the culmination of many months of work for our dedicated team. We hope that you find the end product worthy of our collective efforts and a fitting home for essential bioscience research.